Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

IHG says still on track to meet FY estimates despite Trump trade war

(Sharecast News) - InterContinental Hotels Group said it was on track to meet full-year consensus profit estimates, despite softer economic indicators and the impact of US tariffs and immigration policies. The Holiday Inn and Kimpton owner reported a 3.3% jump in global first quarter revenue per available room (RevPAR), a key industry metric, up from 2.6% last year. Analysts expect IHG to report adjusted core earnings of £1.32bn for the full year.

Americas RevPAR increased 3.5% led by continued growth in the US, and EMEAA rose 5%. In Greater China a 3.5% fall was similar to the previous quarter, as IHG came up against strong comparatives and further increases in outbound leisure travel.

"The outlook of attractive long-term structural growth drivers for both demand and supply remain unaltered for the travel industry and for IHG in particular," the group said on Thursday.

US President Donald Trump's global tariff war has sparked fears of a recession in the world's biggest economy and the detention of tourists for perceived visa violations has seen a strong decline in travellers to the country.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.